Primary androgen deprivation therapy in men with prostate cancer.
Laufman
Leslie
L
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000401:mortality*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal